Changes are being made to the Manage Your Service (MYS) pharmacy portal, aimed at improving user experience. The new-look portal will be launched on Thursday 21 August 2025. Please note: the MYS portal will be temporarily unavailable between 7:00am to 8:30am on Thursday 21 August 2025 whilst NHS Business Services Authority (NHSBSA) make the changes. The [...]
The post Upcoming changes to the MYS Portal appeared first on Community Pharmacy England.
MHRA Class 4 Medicines Defect Notification: Olmesartan medoxomil 10mg film-coated tablets (Jubilant Pharmaceuticals NV) Date issued: 31 July 2025 Drug Alert Number: EL(25)A/37 Jubilant Pharmaceuticals NV has informed the MHRA that the Patient Information leaflet (PIL) in the cartons for the batches listed in this notification include an outdated PIL. DMRC reference number: DMRC-34866997 Marketing Authorisation [...]
The post MHRA Class 4 Medicines Defect Notification: Olmesartan medoxomil 10mg film-coated tablets (Jubilant Pharmaceuticals NV) appeared first on Community Pharmacy England.
Community Pharmacy England on behalf of pharmacy owners made further applications to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), resulting in a further 8 new products being added to the ‘Drugs for which Discount is Not Deducted’ (DND) list from 1 August 2025. This takes the total [...]
The post 8 products added to the Discount Not Deducted (DND) list from August 2025 appeared first on Community Pharmacy England.
The NHS Business Services Authority (NHSBSA) produces a quarterly newsletter called “Hints & Tips for dispensing contractors”. The latest edition (Issue 60) contains some useful information and advice on: CPAF screening questionnaire closes Thursday 31 July 2025 NHS Pharmacy First Service: fixed payment arrangement and capping changes NHS Pharmacy First Service: claim window changes Help [...]
The post NHSBSA ‘Hints & Tips’ – Issue 60 appeared first on Community Pharmacy England.
The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Venlafaxine 37.5mg modified-release tablets are now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP083 Venlafaxine 37.5mg modified-release tablets expires at 23.59pm on Tuesday 22nd July 2025. After this date, any prescriptions for Venlafaxine 37.5mg modified-release [...]
The post Expiry of SSP083 Venlafaxine 37.5mg modified-release tablets appeared first on Community Pharmacy England.
Recent Comments